SlideShare a Scribd company logo
1 of 13
Особливості Тестування у Healthcare IT
к.б.н. ВІТАЛІЙ СТАДНИК
Директор Стратегічних Ініціатив
Про що ми будемо говорити?
- Особливості розробки рішень у Healthcare
- Механізми та способи тестування
- Взаємодії у команді
Особливості розробки рішень у Healthcare
- Доменна експертиза
- Комплексність рішень
- Жорстка Регуляція
Доменна експертиза
Комплексність рішень
HIS – Hospital (Healthcare, Clinical) Information System
LIS – Laboratory Information System (HIPAA regulated)
LIMS – Laboratory Information Management System (GMP and GLP regulated)
Specific Laboratory Applications
The Health Insurance Portability and Accountability Act of 1996
HIPAA
- Title II: Preventing Health Care Fraud and Abuse;
Administrative Simplification; Medical Liability Reform
Жорстка Регуляція
• Driver=Patient Safety
• FDA goal: Medical Device safety and effectiveness
• Definition of a Medical Device by FDA
• "an instrument, apparatus, implement, machine, contrivance,
implant, in vitro reagent, or other similar or related article,
including a component part, or accessory which is:
• Recognized in the official National Formulary, or the United
States Pharmacopoeia, or any supplement to them,
• Intended for use in the diagnosis of disease or other
conditions, or in the cure, mitigation, treatment, or
prevention of disease, in man or other animals, or
• Intended to affect the structure or any function of the body of
man or other animals, and which does not achieve its primary
intended purposes through chemical action within or on the
body of man or other animals and which is not dependent
upon being metabolized for the achievement of any of its
primary intended purposes."
Жах під назвою FDA
The Food and Drug Administration
TGA
Therapeutic Goods Administration
Advisory Committee on Medical Devices (ACMD)
Advisory Committee on the Safety of Medical Devices (ACSMD)
Доступ до клієнтських середовищ
European Union
General Data Protection Regulation
Механізми Тестування
- Change Testing
- Exploratory Testing
- Regression Testing
- Acceptance Testing
- Test Scripts Validation
Traceability
Project
Product
Issue (Ticket) Requirements
Test Case
Change Requests
Взаємодії у Команді
- Advanced communication with BA/PO teams
- Engagement with client
- Cross-functional teams
Questions?

More Related Content

What's hot

Why validation matters: A Brief Guide to a Critical Aspect of the Pharmaceut...
Why validation matters:  A Brief Guide to a Critical Aspect of the Pharmaceut...Why validation matters:  A Brief Guide to a Critical Aspect of the Pharmaceut...
Why validation matters: A Brief Guide to a Critical Aspect of the Pharmaceut...
Barry Peters
 
Outsourcing bioavailibility and bioequivalence studies to contract research
Outsourcing bioavailibility and bioequivalence studies to contract researchOutsourcing bioavailibility and bioequivalence studies to contract research
Outsourcing bioavailibility and bioequivalence studies to contract research
Gauravchaudhary199
 
Responding To A 483and Warning Letter
Responding To A 483and Warning LetterResponding To A 483and Warning Letter
Responding To A 483and Warning Letter
John E. Osani
 

What's hot (20)

Drug Regulatory Affairs
Drug Regulatory AffairsDrug Regulatory Affairs
Drug Regulatory Affairs
 
Drug Safety – An Overview of FDA Powers under FDAAA
Drug Safety – An Overview of FDA Powers under FDAAADrug Safety – An Overview of FDA Powers under FDAAA
Drug Safety – An Overview of FDA Powers under FDAAA
 
Regulatory Affairs Certification Dumps
Regulatory Affairs Certification DumpsRegulatory Affairs Certification Dumps
Regulatory Affairs Certification Dumps
 
Process Validation & Regulatory Strategies for Fast-track and Breakthrough Th...
Process Validation & Regulatory Strategies for Fast-track and Breakthrough Th...Process Validation & Regulatory Strategies for Fast-track and Breakthrough Th...
Process Validation & Regulatory Strategies for Fast-track and Breakthrough Th...
 
Fleek pharma Services
Fleek pharma ServicesFleek pharma Services
Fleek pharma Services
 
Regulatory Affairs as a Career Path
Regulatory Affairs as a Career PathRegulatory Affairs as a Career Path
Regulatory Affairs as a Career Path
 
Regulatory & Quality Challenges of Combination Products
Regulatory & Quality Challenges of Combination ProductsRegulatory & Quality Challenges of Combination Products
Regulatory & Quality Challenges of Combination Products
 
Why validation matters: A Brief Guide to a Critical Aspect of the Pharmaceut...
Why validation matters:  A Brief Guide to a Critical Aspect of the Pharmaceut...Why validation matters:  A Brief Guide to a Critical Aspect of the Pharmaceut...
Why validation matters: A Brief Guide to a Critical Aspect of the Pharmaceut...
 
Drug Delivery -- Perspectives on the FDA Regulatory Environment
Drug Delivery -- Perspectives on the FDA Regulatory EnvironmentDrug Delivery -- Perspectives on the FDA Regulatory Environment
Drug Delivery -- Perspectives on the FDA Regulatory Environment
 
Cmc presentation
Cmc presentationCmc presentation
Cmc presentation
 
OUTSOURCING BIOAVAILABILITY AND BIOEQUIVALENCE TO CRO
OUTSOURCING BIOAVAILABILITY AND BIOEQUIVALENCE TO CROOUTSOURCING BIOAVAILABILITY AND BIOEQUIVALENCE TO CRO
OUTSOURCING BIOAVAILABILITY AND BIOEQUIVALENCE TO CRO
 
Outsourcing bioavailibility and bioequivalence studies to contract research
Outsourcing bioavailibility and bioequivalence studies to contract researchOutsourcing bioavailibility and bioequivalence studies to contract research
Outsourcing bioavailibility and bioequivalence studies to contract research
 
Pharmacovigilance audit
Pharmacovigilance auditPharmacovigilance audit
Pharmacovigilance audit
 
Healthcare &Pharmaceutical
Healthcare &PharmaceuticalHealthcare &Pharmaceutical
Healthcare &Pharmaceutical
 
Combination Products, Orphan Drugs and OTC Drugs
Combination Products, Orphan Drugs and OTC DrugsCombination Products, Orphan Drugs and OTC Drugs
Combination Products, Orphan Drugs and OTC Drugs
 
Oligonucleotide Therapeutics: Brief Overview of the State of the Market
Oligonucleotide Therapeutics: Brief Overview of the State of the MarketOligonucleotide Therapeutics: Brief Overview of the State of the Market
Oligonucleotide Therapeutics: Brief Overview of the State of the Market
 
Responding To A 483and Warning Letter
Responding To A 483and Warning LetterResponding To A 483and Warning Letter
Responding To A 483and Warning Letter
 
Stability Testing of Pharmaceuticals and Supplements
Stability Testing of Pharmaceuticals and SupplementsStability Testing of Pharmaceuticals and Supplements
Stability Testing of Pharmaceuticals and Supplements
 
How to access and process FDA drug approval packages for use in research
How to access and process FDA drug approval packages for use in researchHow to access and process FDA drug approval packages for use in research
How to access and process FDA drug approval packages for use in research
 
Regulatory Affairs Excellence: Staffing and Performance in Medical Device Com...
Regulatory Affairs Excellence: Staffing and Performance in Medical Device Com...Regulatory Affairs Excellence: Staffing and Performance in Medical Device Com...
Regulatory Affairs Excellence: Staffing and Performance in Medical Device Com...
 

Similar to ВІТАЛІЙ СТАДНИК «Особливості Тестування у Healthcare IT» QADay 2019

Reg summary
Reg summaryReg summary
Reg summary
ruyang89
 
Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management, Chal...
Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management, Chal...Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management, Chal...
Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management, Chal...
Bhaswat Chakraborty
 
Introduction to Pharma and Healthcare IT-Anirban
Introduction to Pharma  and Healthcare IT-AnirbanIntroduction to Pharma  and Healthcare IT-Anirban
Introduction to Pharma and Healthcare IT-Anirban
Dr. Anirban Mukherjee, PhD
 

Similar to ВІТАЛІЙ СТАДНИК «Особливості Тестування у Healthcare IT» QADay 2019 (20)

FDA 2013 Clinical Investigator Training Course: Issues in Clinical Trial Desi...
FDA 2013 Clinical Investigator Training Course: Issues in Clinical Trial Desi...FDA 2013 Clinical Investigator Training Course: Issues in Clinical Trial Desi...
FDA 2013 Clinical Investigator Training Course: Issues in Clinical Trial Desi...
 
ISO 14155.pdf
ISO 14155.pdfISO 14155.pdf
ISO 14155.pdf
 
Jason Gillette CV
Jason Gillette CVJason Gillette CV
Jason Gillette CV
 
USFDA NDA Vs BLA
USFDA NDA Vs BLAUSFDA NDA Vs BLA
USFDA NDA Vs BLA
 
Reg summary
Reg summaryReg summary
Reg summary
 
Medical Device Trials.pptx
Medical Device Trials.pptxMedical Device Trials.pptx
Medical Device Trials.pptx
 
FDA’s approach to regulation of in vitro diagnostic tests
FDA’s approach to regulation of in vitro diagnostic testsFDA’s approach to regulation of in vitro diagnostic tests
FDA’s approach to regulation of in vitro diagnostic tests
 
IGPA Building a Culture of Quality Ajaz Hussain_5 Sept 2015_Rferences min
IGPA Building a Culture of Quality Ajaz Hussain_5 Sept 2015_Rferences minIGPA Building a Culture of Quality Ajaz Hussain_5 Sept 2015_Rferences min
IGPA Building a Culture of Quality Ajaz Hussain_5 Sept 2015_Rferences min
 
New Drug Development Process
New Drug Development ProcessNew Drug Development Process
New Drug Development Process
 
mHealth Israel_Digital Health Regulation and the FDA
mHealth Israel_Digital Health Regulation and the FDAmHealth Israel_Digital Health Regulation and the FDA
mHealth Israel_Digital Health Regulation and the FDA
 
KCR: Post-Authorisation Safety Studies (PASS) - Is the Ongoing Surveillance a...
KCR: Post-Authorisation Safety Studies (PASS) - Is the Ongoing Surveillance a...KCR: Post-Authorisation Safety Studies (PASS) - Is the Ongoing Surveillance a...
KCR: Post-Authorisation Safety Studies (PASS) - Is the Ongoing Surveillance a...
 
PMS and Outsourcing - Copy.pptx
PMS and Outsourcing - Copy.pptxPMS and Outsourcing - Copy.pptx
PMS and Outsourcing - Copy.pptx
 
Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management, Chal...
Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management, Chal...Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management, Chal...
Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management, Chal...
 
Regulatory submission: Applying GLP in surgical efficacy studies
Regulatory submission: Applying GLP in surgical efficacy studiesRegulatory submission: Applying GLP in surgical efficacy studies
Regulatory submission: Applying GLP in surgical efficacy studies
 
Presentation: Navigating regulation
Presentation: Navigating regulation Presentation: Navigating regulation
Presentation: Navigating regulation
 
Drug Safety – Perspectives on Industry’s Duties in the Post-Vioxx Age
Drug Safety – Perspectives on Industry’s Duties in the Post-Vioxx AgeDrug Safety – Perspectives on Industry’s Duties in the Post-Vioxx Age
Drug Safety – Perspectives on Industry’s Duties in the Post-Vioxx Age
 
FDA - General Wellness: Policy for Low Risk Devices
FDA - General Wellness: Policy for Low Risk DevicesFDA - General Wellness: Policy for Low Risk Devices
FDA - General Wellness: Policy for Low Risk Devices
 
Module 3 requirements for Biologics (peptide/protein medicines)
Module 3 requirements for Biologics (peptide/protein medicines)Module 3 requirements for Biologics (peptide/protein medicines)
Module 3 requirements for Biologics (peptide/protein medicines)
 
Medical Wearable Devices
Medical Wearable DevicesMedical Wearable Devices
Medical Wearable Devices
 
Introduction to Pharma and Healthcare IT-Anirban
Introduction to Pharma  and Healthcare IT-AnirbanIntroduction to Pharma  and Healthcare IT-Anirban
Introduction to Pharma and Healthcare IT-Anirban
 

More from GoQA

More from GoQA (20)

Досвід здачі іспиту ISTQB Expert level: подробиці, перепідготовка, актуальніс...
Досвід здачі іспиту ISTQB Expert level: подробиці, перепідготовка, актуальніс...Досвід здачі іспиту ISTQB Expert level: подробиці, перепідготовка, актуальніс...
Досвід здачі іспиту ISTQB Expert level: подробиці, перепідготовка, актуальніс...
 
АРТЕМ ГРИГОРЕНКО «Покращення процесів найму»
АРТЕМ ГРИГОРЕНКО «Покращення процесів найму»АРТЕМ ГРИГОРЕНКО «Покращення процесів найму»
АРТЕМ ГРИГОРЕНКО «Покращення процесів найму»
 
КАТЕРИНА ЖУПАН «Mobile Testing based on “ISTQB Mobile Application – Syllabus»
КАТЕРИНА ЖУПАН «Mobile Testing based on “ISTQB Mobile Application – Syllabus»КАТЕРИНА ЖУПАН «Mobile Testing based on “ISTQB Mobile Application – Syllabus»
КАТЕРИНА ЖУПАН «Mobile Testing based on “ISTQB Mobile Application – Syllabus»
 
МОРРІС-ВСЕСЛАВ ШОСТАК «Роль QA в індустрії програмного та апаратного забезпеч...
МОРРІС-ВСЕСЛАВ ШОСТАК «Роль QA в індустрії програмного та апаратного забезпеч...МОРРІС-ВСЕСЛАВ ШОСТАК «Роль QA в індустрії програмного та апаратного забезпеч...
МОРРІС-ВСЕСЛАВ ШОСТАК «Роль QA в індустрії програмного та апаратного забезпеч...
 
ОКСАНА ГОРОЩУК «Improving Quality Through Root Cause Analysis»
ОКСАНА ГОРОЩУК «Improving Quality Through Root Cause Analysis»ОКСАНА ГОРОЩУК «Improving Quality Through Root Cause Analysis»
ОКСАНА ГОРОЩУК «Improving Quality Through Root Cause Analysis»
 
ПАВЛО САФОНОВ «Як оцінити ефективність автоматизації»
ПАВЛО САФОНОВ «Як оцінити ефективність автоматизації»ПАВЛО САФОНОВ «Як оцінити ефективність автоматизації»
ПАВЛО САФОНОВ «Як оцінити ефективність автоматизації»
 
ГАННА КІЛІМОВА & СВІТЛАНА ЯКОВЛЄВА «ADA testing – те, що дуже на часі»
ГАННА КІЛІМОВА & СВІТЛАНА ЯКОВЛЄВА «ADA testing – те, що дуже на часі»ГАННА КІЛІМОВА & СВІТЛАНА ЯКОВЛЄВА «ADA testing – те, що дуже на часі»
ГАННА КІЛІМОВА & СВІТЛАНА ЯКОВЛЄВА «ADA testing – те, що дуже на часі»
 
СЕРГІЙ БРИТ «Як запускати тести з Playwright Java написані на Selenide. Не пе...
СЕРГІЙ БРИТ «Як запускати тести з Playwright Java написані на Selenide. Не пе...СЕРГІЙ БРИТ «Як запускати тести з Playwright Java написані на Selenide. Не пе...
СЕРГІЙ БРИТ «Як запускати тести з Playwright Java написані на Selenide. Не пе...
 
БОГДАН САВЧУК «IoT testing: Manual, Automation and Cyber Security techniques»
БОГДАН САВЧУК «IoT testing: Manual, Automation and Cyber Security techniques»БОГДАН САВЧУК «IoT testing: Manual, Automation and Cyber Security techniques»
БОГДАН САВЧУК «IoT testing: Manual, Automation and Cyber Security techniques»
 
ЕЛЬМІР ІСКАНДЕРОВ «Bulletproof Your Software: The Magic of Security Autotests»
ЕЛЬМІР ІСКАНДЕРОВ «Bulletproof Your Software: The Magic of Security Autotests»ЕЛЬМІР ІСКАНДЕРОВ «Bulletproof Your Software: The Magic of Security Autotests»
ЕЛЬМІР ІСКАНДЕРОВ «Bulletproof Your Software: The Magic of Security Autotests»
 
ІННА ДВОЙНІКОВА «Як вийти на Upwork та розширити горизонти QA»
ІННА ДВОЙНІКОВА «Як вийти на Upwork та розширити горизонти QA»ІННА ДВОЙНІКОВА «Як вийти на Upwork та розширити горизонти QA»
ІННА ДВОЙНІКОВА «Як вийти на Upwork та розширити горизонти QA»
 
КАТЕРИНА АБЗЯТОВА «Point of Growth: Transforming Challenges into Skill-Buildi...
КАТЕРИНА АБЗЯТОВА «Point of Growth: Transforming Challenges into Skill-Buildi...КАТЕРИНА АБЗЯТОВА «Point of Growth: Transforming Challenges into Skill-Buildi...
КАТЕРИНА АБЗЯТОВА «Point of Growth: Transforming Challenges into Skill-Buildi...
 
НАТАЛІЯ ТРОЙНІЧ «Редизайн всього продукту, коли на проекті залишилось два ман...
НАТАЛІЯ ТРОЙНІЧ «Редизайн всього продукту, коли на проекті залишилось два ман...НАТАЛІЯ ТРОЙНІЧ «Редизайн всього продукту, коли на проекті залишилось два ман...
НАТАЛІЯ ТРОЙНІЧ «Редизайн всього продукту, коли на проекті залишилось два ман...
 
РІНА УЖЕВКО «Вплив архітектури на стратегію тестування»
РІНА УЖЕВКО «Вплив архітектури на стратегію тестування»РІНА УЖЕВКО «Вплив архітектури на стратегію тестування»
РІНА УЖЕВКО «Вплив архітектури на стратегію тестування»
 
СЕРГІЙ РУСІНЧУК «Розкриття майстерності QA команд через KPI»
СЕРГІЙ РУСІНЧУК «Розкриття майстерності QA команд через KPI»СЕРГІЙ РУСІНЧУК «Розкриття майстерності QA команд через KPI»
СЕРГІЙ РУСІНЧУК «Розкриття майстерності QA команд через KPI»
 
КАТЕРИНА АБЗЯТОВА - Certify with confidence: ISTQB Foundation 4.0. Common err...
КАТЕРИНА АБЗЯТОВА - Certify with confidence: ISTQB Foundation 4.0. Common err...КАТЕРИНА АБЗЯТОВА - Certify with confidence: ISTQB Foundation 4.0. Common err...
КАТЕРИНА АБЗЯТОВА - Certify with confidence: ISTQB Foundation 4.0. Common err...
 
Слуцька Вікторія - Виступити і не наступити на граблі: Як виступати QA спеціа...
Слуцька Вікторія - Виступити і не наступити на граблі: Як виступати QA спеціа...Слуцька Вікторія - Виступити і не наступити на граблі: Як виступати QA спеціа...
Слуцька Вікторія - Виступити і не наступити на граблі: Як виступати QA спеціа...
 
ОЛЕКСАНДР ХОТЕМСЬКИЙ «Планування стратегії розвитку тестування на проекті»
ОЛЕКСАНДР ХОТЕМСЬКИЙ «Планування стратегії розвитку тестування на проекті»ОЛЕКСАНДР ХОТЕМСЬКИЙ «Планування стратегії розвитку тестування на проекті»
ОЛЕКСАНДР ХОТЕМСЬКИЙ «Планування стратегії розвитку тестування на проекті»
 
ОЛЕКСІЙ ОСТАПОВ «Створення плагінів для pytest»
ОЛЕКСІЙ ОСТАПОВ «Створення плагінів для pytest»ОЛЕКСІЙ ОСТАПОВ «Створення плагінів для pytest»
ОЛЕКСІЙ ОСТАПОВ «Створення плагінів для pytest»
 
РОМАН ДУМАНСЬКИЙ «Testing the application in the Amazon Cloud»
РОМАН ДУМАНСЬКИЙ «Testing the application in the Amazon Cloud»РОМАН ДУМАНСЬКИЙ «Testing the application in the Amazon Cloud»
РОМАН ДУМАНСЬКИЙ «Testing the application in the Amazon Cloud»
 

Recently uploaded

Personalisation of Education by AI and Big Data - Lourdes Guàrdia
Personalisation of Education by AI and Big Data - Lourdes GuàrdiaPersonalisation of Education by AI and Big Data - Lourdes Guàrdia
Personalisation of Education by AI and Big Data - Lourdes Guàrdia
EADTU
 

Recently uploaded (20)

What is 3 Way Matching Process in Odoo 17.pptx
What is 3 Way Matching Process in Odoo 17.pptxWhat is 3 Way Matching Process in Odoo 17.pptx
What is 3 Way Matching Process in Odoo 17.pptx
 
Diuretic, Hypoglycemic and Limit test of Heavy metals and Arsenic.-1.pdf
Diuretic, Hypoglycemic and Limit test of Heavy metals and Arsenic.-1.pdfDiuretic, Hypoglycemic and Limit test of Heavy metals and Arsenic.-1.pdf
Diuretic, Hypoglycemic and Limit test of Heavy metals and Arsenic.-1.pdf
 
How to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptxHow to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptx
 
TỔNG HỢP HƠN 100 ĐỀ THI THỬ TỐT NGHIỆP THPT TOÁN 2024 - TỪ CÁC TRƯỜNG, TRƯỜNG...
TỔNG HỢP HƠN 100 ĐỀ THI THỬ TỐT NGHIỆP THPT TOÁN 2024 - TỪ CÁC TRƯỜNG, TRƯỜNG...TỔNG HỢP HƠN 100 ĐỀ THI THỬ TỐT NGHIỆP THPT TOÁN 2024 - TỪ CÁC TRƯỜNG, TRƯỜNG...
TỔNG HỢP HƠN 100 ĐỀ THI THỬ TỐT NGHIỆP THPT TOÁN 2024 - TỪ CÁC TRƯỜNG, TRƯỜNG...
 
Including Mental Health Support in Project Delivery, 14 May.pdf
Including Mental Health Support in Project Delivery, 14 May.pdfIncluding Mental Health Support in Project Delivery, 14 May.pdf
Including Mental Health Support in Project Delivery, 14 May.pdf
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024
 
21st_Century_Skills_Framework_Final_Presentation_2.pptx
21st_Century_Skills_Framework_Final_Presentation_2.pptx21st_Century_Skills_Framework_Final_Presentation_2.pptx
21st_Century_Skills_Framework_Final_Presentation_2.pptx
 
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
 
UGC NET Paper 1 Unit 7 DATA INTERPRETATION.pdf
UGC NET Paper 1 Unit 7 DATA INTERPRETATION.pdfUGC NET Paper 1 Unit 7 DATA INTERPRETATION.pdf
UGC NET Paper 1 Unit 7 DATA INTERPRETATION.pdf
 
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxHMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
 
Personalisation of Education by AI and Big Data - Lourdes Guàrdia
Personalisation of Education by AI and Big Data - Lourdes GuàrdiaPersonalisation of Education by AI and Big Data - Lourdes Guàrdia
Personalisation of Education by AI and Big Data - Lourdes Guàrdia
 
When Quality Assurance Meets Innovation in Higher Education - Report launch w...
When Quality Assurance Meets Innovation in Higher Education - Report launch w...When Quality Assurance Meets Innovation in Higher Education - Report launch w...
When Quality Assurance Meets Innovation in Higher Education - Report launch w...
 
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxHMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
 
OSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & SystemsOSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & Systems
 
Observing-Correct-Grammar-in-Making-Definitions.pptx
Observing-Correct-Grammar-in-Making-Definitions.pptxObserving-Correct-Grammar-in-Making-Definitions.pptx
Observing-Correct-Grammar-in-Making-Definitions.pptx
 
AIM of Education-Teachers Training-2024.ppt
AIM of Education-Teachers Training-2024.pptAIM of Education-Teachers Training-2024.ppt
AIM of Education-Teachers Training-2024.ppt
 
Model Attribute _rec_name in the Odoo 17
Model Attribute _rec_name in the Odoo 17Model Attribute _rec_name in the Odoo 17
Model Attribute _rec_name in the Odoo 17
 
Wellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxWellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptx
 
diagnosting testing bsc 2nd sem.pptx....
diagnosting testing bsc 2nd sem.pptx....diagnosting testing bsc 2nd sem.pptx....
diagnosting testing bsc 2nd sem.pptx....
 
Details on CBSE Compartment Exam.pptx1111
Details on CBSE Compartment Exam.pptx1111Details on CBSE Compartment Exam.pptx1111
Details on CBSE Compartment Exam.pptx1111
 

ВІТАЛІЙ СТАДНИК «Особливості Тестування у Healthcare IT» QADay 2019

  • 1. Особливості Тестування у Healthcare IT к.б.н. ВІТАЛІЙ СТАДНИК Директор Стратегічних Ініціатив
  • 2. Про що ми будемо говорити? - Особливості розробки рішень у Healthcare - Механізми та способи тестування - Взаємодії у команді
  • 3. Особливості розробки рішень у Healthcare - Доменна експертиза - Комплексність рішень - Жорстка Регуляція
  • 5. Комплексність рішень HIS – Hospital (Healthcare, Clinical) Information System LIS – Laboratory Information System (HIPAA regulated) LIMS – Laboratory Information Management System (GMP and GLP regulated) Specific Laboratory Applications
  • 6. The Health Insurance Portability and Accountability Act of 1996 HIPAA - Title II: Preventing Health Care Fraud and Abuse; Administrative Simplification; Medical Liability Reform Жорстка Регуляція
  • 7. • Driver=Patient Safety • FDA goal: Medical Device safety and effectiveness • Definition of a Medical Device by FDA • "an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including a component part, or accessory which is: • Recognized in the official National Formulary, or the United States Pharmacopoeia, or any supplement to them, • Intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, in man or other animals, or • Intended to affect the structure or any function of the body of man or other animals, and which does not achieve its primary intended purposes through chemical action within or on the body of man or other animals and which is not dependent upon being metabolized for the achievement of any of its primary intended purposes." Жах під назвою FDA The Food and Drug Administration
  • 8. TGA Therapeutic Goods Administration Advisory Committee on Medical Devices (ACMD) Advisory Committee on the Safety of Medical Devices (ACSMD)
  • 9. Доступ до клієнтських середовищ European Union General Data Protection Regulation
  • 10. Механізми Тестування - Change Testing - Exploratory Testing - Regression Testing - Acceptance Testing - Test Scripts Validation
  • 12. Взаємодії у Команді - Advanced communication with BA/PO teams - Engagement with client - Cross-functional teams